CIM LLC’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-189,399
| Closed | -$14M | – | 164 |
|
|
2024
Q4 | $14M | Buy |
189,399
+2,337
| +1% | +$164K | 2% | 22 |
|
|
2024
Q3 | $12.3M | Buy |
187,062
+293
| +0.2% | +$21.3K | 1.78% | 22 |
|
|
2024
Q2 | $12.3M | Buy |
186,769
+2,641
| +1% | +$234K | 1.85% | 21 |
|
|
2024
Q1 | $17.6M | Buy |
184,128
+4,135
| +2% | +$347K | 2.66% | 16 |
|
|
2023
Q4 | $15.8M | Sell |
179,993
-1,912
| -1% | -$133K | 2.46% | 18 |
|
|
2023
Q3 | $12.6M | Sell |
181,905
-5,456
| -3% | -$438K | 2.4% | 20 |
|
|
2023
Q2 | $17.7M | Sell |
187,361
-2,486
| -1% | -$216K | 3.3% | 7 |
|
|
2023
Q1 | $15.7M | Sell |
189,847
-439
| -0.2% | -$34.5K | 3.11% | 13 |
|
|
2022
Q4 | $14.7M | Buy |
190,286
+29,458
| +18% | +$2.27M | 2.92% | 15 |
|
|
2022
Q3 | $11.7M | Sell |
160,828
-2,657
| -2% | -$256K | 2.46% | 17 |
|
|
2022
Q2 | $16.1M | Sell |
163,485
-2,637
| -2% | -$273K | 3.34% | 8 |
|
|
2022
Q1 | $20.2M | Sell |
166,122
-9,850
| -6% | -$1.1M | 3.76% | 4 |
|
|
2021
Q4 | $19.3M | Sell |
175,972
-4,440
| -2% | -$518K | 3.6% | 7 |
|
|
2021
Q3 | $21.4M | Sell |
180,412
-1,877
| -1% | -$214K | 3.33% | 9 |
|
|
2021
Q2 | $21M | Buy |
182,289
+1,415
| +0.8% | +$133K | 3.42% | 10 |
|
|
2021
Q1 | $16.4M | Sell |
180,874
-11,976
| -6% | -$1.01M | 2.93% | 15 |
|
|
2020
Q4 | $16.4M | Buy |
192,850
+668
| +0.3% | +$55.4K | 3.03% | 11 |
|
|
2020
Q3 | $14.9M | Buy |
192,182
+2,518
| +1% | +$196K | 3.04% | 13 |
|
|
2020
Q2 | $13.1M | Sell |
189,664
-1,322
| -0.7% | -$94K | 3.84% | 8 |
|
|
2020
Q1 | $12M | Sell |
190,986
-426
| -0.2% | -$30.7K | 4.56% | 3 |
|
|
2019
Q4 | $14.9M | Sell |
191,412
-32,493
| -15% | -$2.54M | 4.66% | 2 |
|
|
2019
Q3 | $16.4M | Sell |
223,905
-10,086
| -4% | -$709K | 5.66% | 1 |
|
|
2019
Q2 | $14.4M | Buy |
233,991
+1,707
| +0.7% | +$103K | 4.97% | 3 |
|
|
2019
Q1 | $14.8M | Sell |
232,284
-7,905
| -3% | -$451K | 5.44% | 2 |
|
|
2018
Q4 | $12.3M | Sell |
240,189
-6,126
| -2% | -$310K | 5.36% | 1 |
|
|
2018
Q3 | $14.3M | Sell |
246,315
-31,524
| -11% | -$1.54M | 5.22% | 1 |
|
|
2018
Q2 | $13.5M | Sell |
277,839
-1,344
| -0.5% | -$62.7K | 4.86% | 3 |
|
|
2018
Q1 | $13M | Buy |
279,183
+11,454
| +4% | +$497K | 5.04% | 3 |
|
|
2017
Q4 | $10.1M | Buy |
267,729
+19,860
| +8% | +$729K | 3.94% | 11 |
|
|
2017
Q3 | $9.03M | Sell |
247,869
-1,107
| -0.4% | -$42.2K | 3.74% | 13 |
|
|
2017
Q2 | $9.81M | Sell |
248,976
-2,520
| -1% | -$92K | 4.2% | 8 |
|
|
2017
Q1 | $7.89M | Buy |
+251,496
| New | +$7.87M | 3.56% | 15 |
|
|
2016
Q4 | – | Sell |
-267,507
| Closed | -$10.8M | – | 88 |
|
|
2016
Q3 | $10.8M | Sell |
267,507
-68,970
| -20% | -$2.6M | 5.04% | 1 |
|
|
2016
Q2 | $11.2M | Sell |
336,477
-9,387
| -3% | -$321K | 5.59% | 1 |
|
|
2016
Q1 | $10.2M | Sell |
345,864
-12,606
| -4% | -$348K | 5.03% | 1 |
|
|
2015
Q4 | $9.44M | Buy |
358,470
+335,760
| +1,478% | +$8.72M | 4.58% | 8 |
|
|
2015
Q3 | $538K | Sell |
22,710
-306
| -1% | -$7.39K | 0.27% | 30 |
|
|
2015
Q2 | $546K | Buy |
23,016
+480
| +2% | +$10.8K | 0.26% | 34 |
|
|
2015
Q1 | $535K | Sell |
22,536
-1,542
| -6% | -$34.6K | 0.25% | 39 |
|
|
2014
Q4 | $511K | Sell |
24,078
-4,842
| -17% | -$97.3K | 0.24% | 36 |
|
|
2014
Q3 | $492K | Buy |
28,920
+390
| +1% | +$6.16K | 0.24% | 36 |
|
|
2014
Q2 | $408K | Buy |
+28,530
| New | +$387K | 0.21% | 44 |
|
Other funds holding EW
CIM LLC's EW Position: Q1 2025 in Review
CIM LLC sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 189,399 shares — an estimated $14M sold.
CIM LLC first reported a position in EW in Q2 2014 and held it in 42 quarters. The position peaked at $21.4M in Q3 2021. 1,205 funds tracked by Wall St. Rank hold EW as of Q1 2025.
- CIM LLC reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
- CIM LLC sold 189,399 Edwards Lifesciences shares in Q1 2025, an estimated $14M.
- CIM LLC first reported a position in Edwards Lifesciences in Q2 2014 and held it in 42 quarters.
- CIM LLC's Edwards Lifesciences position peaked at $21.4M in Q3 2021.
- 1,205 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.
Based on CIM LLC's 13F filing for Q1 2025, filed 5 Jun 2025.